[1] Fang WL,Wu CW,Chen JH,et a1.Esophagogastric junction ad— enocarcinoma according to Siewert classification in Taiwan『J]. Ann Surg Oneol,2009,16(12):3237—3244.
[2]Huang Q,Fan X,Agoston AT,et a1.Comparison of gastro—oesophageal iunction carcinomas in Chinese versus American patients [J].His/opathology,2011,59(2):188—197.
[3]. Zhao, J, Zhao, J, Du F, et al. Cardia and non-cardia gastric cancer have similar stage-for-stage prognoses after R0 resection: a largescale, multicenter study in China. J Gastrointest Surg.2016;20(4):700–7.
[4]. Carr JS, Zafar SF, Saba N, et al. Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma. J Gastrointest Cancer. 2013;44(2):143–51.
[5]. Saedi HS, Mansour-Ghanaei F, Joukar F, et al. Neoadjuvant chemoradiotherapy in non-cardia gastric cancer patients–does it improve survival? Asian Pac J Cancer Prev. 2014;15(20):8667–71.
[6] Deng K, Yang L, Hu B, Wu H, Zhu H, Tang C. The prognostic significance of pretreatment serum cea levels in gastric cancer: a meta-analysis including 14,651 patients. PLoS ONE. 2015; 4: e124151.
[7] Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow. Lancet. 2001. 357(9255): 539-45.
[8] Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011. 144(5): 646-74.
[9] Gomes de Lima KV, Maio R. Nutritional status, systemic inflammation and prognosis of patients with gastrointestinal cancer. Nutr Hosp2012; 27:707–14.
[10] Nozoe T, Ninomiya M, Maeda T, et al. Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma. Surg Today 2010;40:440–3.
[11] Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32–5.
[12] Zivanovic O, Jacks LM, Iasonos A et al. A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma. Cancer 2012; 118: 660–9.
[13] Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J. Clin. Oncol. Off. J. Am. Soc. Clin.Oncol. 2008; 26: 1364–70.
[14]Zhang L, Su Y, Chen Z, et al. The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction. Medicine (Baltimore). 2017 Jul;96(30):e7647.
[15]Huang L 1, Wei ZJ 1, Li TJ, et al. A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort. Oncotarget.2017 Jul 12;8(40):68165-68179.
[16] Roxburgh CS,Salmond JM,Horgan PG,et al.The relationship between the local and systemic inflammatory responses and survival in patients undergoing curative surgery for colon and rectal cancers[J].J Gastrointest Surg,2009,13:2011-2018.
[17] S.I. Grivennikov, F.R. Greten, M. Karin, Immunity, inflammation, and cancer, Cell140 (2010) 883–899.
[18] Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity [J]. Adv Immunol, 2006,90:1–50.
[19] Evani SJ, Prabhu RG, Gnanaruban V, Finol EA, Ramasubramanian AK. Monocytes mediate metastatic breast tumor cell adhesion to endothelium under flow. FASEB journal. 2013; 27:3017–3029.
[20]Vernaci G , Dieci MV , Manfrin S, et al. BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysis. Breast. 2019 Jul 20;47:77-84.
[21]Yendamuri S , Barbi J , Pabla S, et al. Body mass index (BMI) Influences the Salutary Effects of Metformin on Survival After Lobectomy for Stage I NSCLC. J Thorac Oncol. 2019 Aug 6. pii: S1556-0864(19)30650-1.
[22] Ji F, Liang Y, Fu S, et al. Prognostic value of combined preoperative prognostic nutritional index and body mass index in HCC after hepatectomy. HPB (Oxford) 2017;[Epub ahead of print].